Literature DB >> 8971017

Intrapatient sequence variation of the gag gene of human immunodeficiency virus type 1 plasma virions.

F K Yoshimura1, K Diem, G H Learn, S Riddell, L Corey.   

Abstract

Because certain regions of the gag gene, such as p24, are highly conserved among human immunodeficiency virus (HIV) isolates, many therapeutic strategies have been directed at gag gene targets. Although intrapatient variation of segments of gag have been determined, little is known about the variability of the full-length gag gene for HIV isolated from a single individual. To evaluate intrapatient full-length gag variability, we derived the nucleotide sequences of at least 10 cDNA gag clones of virion RNA isolated from plasma for each of four asymptomatic HIV type 1-infected patients with relatively high CD4+ T-cell counts (300 to 450 cells per mm3). Mean values of intrapatient gag nucleotide variation obtained by pairwise comparisons ranged from 0.55 to 2.86%. For three subjects, this value was equivalent to that reported for intrapatient full-length env variation. The greatest range of intrapatient mean nucleotide variation for individual protein-coding regions was observed for p7. We did not detect any G-to-A hypermutation, as A-to-G and G-to-A transitions occurred at similar frequencies, accounting for 29 and 25%, respectively, of the changes. Mean variation values and phylogenetic analysis suggested that the extent of nucleotide variation correlated with the length of viral infection. Furthermore, no distinct subpopulations of quasispecies were detectable within an individual. The predicted amino acid sequences indicated that there were no regions within a gag protein that were comprised of clustered changes.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8971017      PMCID: PMC190985     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  46 in total

Review 1.  Envelope sequence variation, neutralizing antibodies, and primate lentivirus persistence.

Authors:  D P Burns; R C Desrosiers
Journal:  Curr Top Microbiol Immunol       Date:  1994       Impact factor: 4.291

2.  HIV-1 isolates are rapidly evolving quasispecies: evidence for viral mixtures and preferred nucleotide substitutions.

Authors:  M Goodenow; T Huet; W Saurin; S Kwok; J Sninsky; S Wain-Hobson
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1989

3.  Cellular immune response to viral peptides in patients exposed to HIV.

Authors:  P M Ahearne; T J Matthews; H K Lyerly; G C White; D P Bolognesi; K J Weinhold
Journal:  AIDS Res Hum Retroviruses       Date:  1988-08       Impact factor: 2.205

4.  HIV-1 gag-specific cytotoxic T lymphocytes defined with recombinant vaccinia virus and synthetic peptides.

Authors:  D F Nixon; A R Townsend; J G Elvin; C R Rizza; J Gallwey; A J McMichael
Journal:  Nature       Date:  1988-12-01       Impact factor: 49.962

5.  The neighbor-joining method: a new method for reconstructing phylogenetic trees.

Authors:  N Saitou; M Nei
Journal:  Mol Biol Evol       Date:  1987-07       Impact factor: 16.240

6.  Evolution of the structural proteins of human immunodeficiency virus: selective constraints on nucleotide substitution.

Authors:  A L Brown; P Monaghan
Journal:  AIDS Res Hum Retroviruses       Date:  1988-12       Impact factor: 2.205

7.  Numbers of CD4+ cells and the levels of core antigens of and antibodies to the human immunodeficiency virus as predictors of AIDS among seropositive homosexual men.

Authors:  F de Wolf; J M Lange; J T Houweling; R A Coutinho; P T Schellekens; J van der Noordaa; J Goudsmit
Journal:  J Infect Dis       Date:  1988-09       Impact factor: 5.226

8.  Neutralizing antibodies as a prognostic indicator in the progression of acquired immune deficiency syndrome (AIDS)-related disorders: a double-blind study.

Authors:  Y Sei; P H Tsang; J P Roboz; P S Sarin; J I Wallace; J G Bekesi
Journal:  J Clin Immunol       Date:  1988-11       Impact factor: 8.317

9.  Serial determinations of HIV-1 titers in HIV-infected homosexual men: association of rising titers with CD4 T cell depletion and progression to AIDS.

Authors:  J K Nicholson; T J Spira; C H Aloisio; B M Jones; M S Kennedy; R C Holman; J S McDougal
Journal:  AIDS Res Hum Retroviruses       Date:  1989-04       Impact factor: 2.205

10.  Decline of anti-p24 antibody precedes antigenaemia as correlate of prognosis in HIV-1 infection.

Authors:  S M Forster; L M Osborne; R Cheingsong-Popov; C Kenny; R Burnell; D J Jeffries; A J Pinching; J R Harris; J N Weber
Journal:  AIDS       Date:  1987-12       Impact factor: 4.177

View more
  15 in total

Review 1.  Transition between stochastic evolution and deterministic evolution in the presence of selection: general theory and application to virology.

Authors:  I M Rouzine; A Rodrigo; J M Coffin
Journal:  Microbiol Mol Biol Rev       Date:  2001-03       Impact factor: 11.056

2.  HIV-1 Gag shares a signature motif with annexin (Anx7), which is required for virus replication.

Authors:  M Srivastava; M Cartas; T A Rizvi; S P Singh; D Serio; V S Kalyanaraman; H B Pollard; A Srinivasan
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

3.  Substitutions in the reverse transcriptase and protease genes of HIV-1 subtype B in untreated individuals and patients treated with antiretroviral drugs.

Authors:  Dan Turner; Bluma Brenner; Daniela Mosis; Chen Liang; Mark A Wainberg
Journal:  MedGenMed       Date:  2005-03-24

4.  Virus population homogenization following acute human immunodeficiency virus type 1 infection.

Authors:  Gerald H Learn; David Muthui; Scott J Brodie; Tuofu Zhu; Kurt Diem; James I Mullins; Lawrence Corey
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

5.  Effect of macromolecular crowding agents on human immunodeficiency virus type 1 capsid protein assembly in vitro.

Authors:  Marta del Alamo; Germán Rivas; Mauricio G Mateu
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

6.  Resistance to nucleoside analog reverse transcriptase inhibitors mediated by human immunodeficiency virus type 1 p6 protein.

Authors:  S Peters; M Muñoz; S Yerly; V Sanchez-Merino; C Lopez-Galindez; L Perrin; B Larder; D Cmarko; S Fakan; P Meylan; A Telenti
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

7.  Kinetics of formation of hypoxanthine containing base pairs by HIV-RT: RNA template effects on the base substitution frequencies.

Authors:  M R Valentine; J Termini
Journal:  Nucleic Acids Res       Date:  2001-03-01       Impact factor: 16.971

8.  Brain cell reservoirs of latent virus in presymptomatic HIV-infected individuals.

Authors:  Katherine A Thompson; Catherine L Cherry; Jeanne E Bell; Catriona A McLean
Journal:  Am J Pathol       Date:  2011-08-24       Impact factor: 4.307

9.  A classification approach for genotyping viral sequences based on multidimensional scaling and linear discriminant analysis.

Authors:  Jiwoong Kim; Yongju Ahn; Kichan Lee; Sung Hee Park; Sangsoo Kim
Journal:  BMC Bioinformatics       Date:  2010-08-21       Impact factor: 3.169

10.  Substitutions in the Reverse Transcriptase and Protease Genes of HIV-1 Subtype B in Untreated Individuals and Patients Treated With Antiretroviral Drugs.

Authors:  Dan Turner; Bluma Brenner; Daniela Moisi; Chen Liang; Mark A Wainberg
Journal:  J Int AIDS Soc       Date:  2005-03-23       Impact factor: 5.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.